Live feed09:46:54·93dINSIDERFilingvia QuantisnowEVP, CRO & Pres. Life Sciences Feld Michael sold $15,205 worth of shares (75 units at $202.73), decreasing direct ownership by 0.45% to 16,431 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.BDX· Becton Dickinson and CompanyHealth CareOriginal source